Cresco Labs: Cantor Lowers Price Target To $12.65

On September 3, Cresco Labs (CSE: CL) announced that they closed their acquisition of Cultivate, a vertically integrated Massachusetts operator that was acquired for $90 million, plus a potential $68 million earn-out. Cultivate currently operates roughly 42,000 square feet of active canopy with an additional 20,000 square feet of canopy available for build-out. The company has 3 open dispensaries.

Cresco Labs currently has 17 analysts covering the name with an average 12-month price target of $23.97, or a 104% upside. Out of the 17 analysts, 5 have strong buy ratings, 11 have buy ratings and 1 analyst has a hold rating. The street high sits at $34 from Stifel-GMP while the lowest comes in at $18.

Cantor Fitzgerald sent out a note last week updating their model, and with that lowering their 12-month price target to $12.65 from $13.50 while reiterating their overweight rating. On the Cultivate deal, Cantor says that they are factoring in an increase of $9 million in revenue since the deal closed earlier than expected.

Cantor says that the company has a strong presence in Illinois and Pennsylvania, with them being a #1 or #2 retailer/wholesaler in those states respectively, but according to Cantor’s channel checks, there is softness in the growth rate for Pennsylvania, California, and Illinois.

Cantor came to the price target by placing 15% on top of the MSO average 2022 EBITDA multiple. This 15% premium to the multiple has been applied for a multitude of reasons, with the biggest being “rec optionality in several states (NY and others), and a more established track record.”

In Illinois, recreational sales dropped 5% month over month, but are up 8% over the second quarter average. This is below the 24% average that the second quarter saw. In Pennslyvania, Headset data shows a 7% month over month drop, and in California, data shows a lower 2% month over month drop.


Information for this briefing was found via Sedar and Refinitiv. The author has no securities or affiliations related to this organization. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security. The author holds no licenses.

Video Articles

Silver @ $36 & We’re Still 200M Oz Short | Paul Andre Huet – Americas Gold and Silver

Gold’s Wild Bull Run: Are Markets About to Break? | Mike McGlone

First Majestic Silver: The Santa Elena Mine

Recommended

Goliath Resources Closes Out Funding Round With Total Gross Proceeds Of $27.1 Million

Silver47 Kickstarts 4,000 Metre Drill Campaign At Red Mountain Project

Related News

BMO Reiterates $21 Price Target On Victoria Gold After Production Results

On January 6th, Victoria Gold Corp. (TSX: VGCX) announced its fourth quarter and annual production...

Saturday, January 8, 2022, 01:08:00 PM

Columbia Care: Canaccord Reiterates $15 Price Target Following Q4 Results

On March 16th, Columbia Care (NEO: CCHW) reported their fourth quarter and year end financials...

Friday, March 19, 2021, 11:47:00 AM

Goodfood: Canaccord Raises Price Target To $11.50 Ahead Of Earnings

This morning, Canaccord Genuity raised their 12-month price target to C$11.50 from C$9.50 and reiterated...

Tuesday, October 27, 2020, 04:26:00 PM

BMO: Cenovus Energy Has “Peer-Leading Cash Return Potential”

On February 8th, Cenovus Energy (TSX: CVE) reported its fourth-quarter and full-year 2021 results. The...

Saturday, February 12, 2022, 05:10:00 PM

Red White & Bloom: PI Initiates Coverage With $2.50 Price Target

This week, PI Financial initiated coverage on Red White & Bloom (CSE: RWB) with a...

Sunday, October 11, 2020, 01:53:00 PM